# City Therapeutics, Inc. (CTY): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for City Therapeutics, Inc. (CTY) is 6/100, ranked against 24,000+ stocks in 35 markets (Quality 27, Value 23, Momentum 25, each scored against its sector).

- StockRank: 6/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 27, Value 23, Momentum 25: each a 0-100 percentile within Healthcare.
- Position: #24,747 overall, #2,429 in Healthcare.
- Listing: United States, NGM; Healthcare / Biotechnology.
- Last close: 20.79 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 3.1M; 5%+ holders bought USD 3.1M.

Source: https://moatmap.ai/stock/CTY
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker